Medicine

Hibernation science utilized to treat weight problems as well as change metabolic rate

.Attributes Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowin...

CAR- T and mobile gene therapies are actually also costly

.Nature Medication, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care ...

The that genomics system of benefit equitable application of human genomics for worldwide health

.The publication of the initial draft of the individual genome sequence in 20011 was followed by the...

A time-stratified, case\u00e2 $ \"crossover study of heat energy direct exposure and also perinatal mortality coming from 16 hospitals in sub-Saharan Africa

.Among 138,015 hospital-based singleton childbirths in 4 sub-Saharan African nations, our company ob...

Advancing worldwide antibiotic research, growth as well as accessibility #.\n\nMurray, C. J. L. et cetera. Global problem of bacterial antimicrobial protection in 2019: a methodical evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Leaders. In the direction of particular commitments and also action in the feedback to antimicrobial protection. Global Frontrunners Group on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Health And Wellness Organization. WHO publishes list of germs for which new antibiotics are quickly needed to have. World Wellness Institution https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Planet Health And Wellness Association. WHO bacterial concern microorganisms checklist, 2024: bacterial microorganisms of public health significance to help research study, growth and also techniques to avoid as well as regulate antimicrobial protection. Globe Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative entry. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Organization. 2023 anti-bacterial brokers in medical as well as preclinical progression: an overview and review. World Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Evaluation. May 19, 2016 \u00e2 $\" Addressing drug-resistant contaminations worldwide: final report as well as referrals. Customer Review on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB outcomes: documents and also rundown. Drive abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall surface: a require collective action on antibiotics research and development. Boston ma Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Brief 51: Just how can the EU help maintainable innovation and accessibility to successful antibiotics? policy options for existing and also brand new medicines. International Observatory on Health Systems and also Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic usage as well as resistance\u00e2 $\" verifying the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Association. 2021 AWaRe distinction. That gain access to, check out, book, category of anti-biotics for evaluation and surveillance of utilization. Planet Health Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Centre for Ailment Avoidance as well as Control. Antimicrobial protection intendeds: how can we reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Wellness Organization. Absence of innovation readied to weaken antibiotic efficiency and health increases. World Health Association https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Just how antimicrobial protection is connected to environment improvement: an introduction of two entwined worldwide challenges. Int. J. Environ. Res. Public Health 20, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial infections: our company need to have critical activity as well as expenditure that pay attention to the weakest web link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. Immunization coverage. World Health and wellness Institution https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination protection as well as control in low-resource setups: the need for the nearby, the contextual as well as the pragmatic. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Obstacles of applying antimicrobial stewardship tools in reduced to center income countries (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A quick past history of the antibiotic period: lessons learned and obstacles for the future. Front. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et cetera. Person access in 14 high-income countries to new antibacterials accepted by the US Fda, European Medicines Company, Japanese Pharmaceuticals as well as Medical Instruments Company, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health Association. 2021 anti-bacterial brokers in scientific as well as preclinical advancement: an introduction and also review. Planet Health Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Anti-biotics: the business economics need to sustain the scientific research. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The condition of technology in antibacterial therapeutics. Medical Technology Association https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Assessing clinician application of next-generation antibiotics versus resisting Gram-negative infections in U.S. medical facilities: a retrospective pal research study. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of advancement in anti-bacterial rehabs. Biotechnology Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. An organized testimonial and also crucial examination of incentive approaches for exploration and progression of unfamiliar anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Emergency Readiness and Feedback Authority. Research and development of clinical countermeasures. European Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Payment. Pre-draft plan for an International partnership under Horizon Europe One Health And Wellness Antimicrobial Resistance. European Percentage https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Global Antibiotic Research and Development Alliance. Entasis Rehabs as well as the Worldwide Antibiotic Research Study &amp Development Alliance to create a brand new therapy for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of industry- and non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health Institution. Amount of professional test registrations through site, condition, period of advancement, grow older as well as sexual activity of trial individuals (1999\u00e2 $ \"2022). Globe Wellness Organization https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Global Antibiotic Experimentation Relationship. NeoSept1: a study to figure out the ranking of existing as well as new prescription antibiotics blends to address newborns that remain in healthcare facility along with severe sepsis. ISRCTN windows registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Company of Canada. Federal government of Canada creates important financial investment to overcome antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Prescription Antibiotic Research and Development Relationship. Asia authorities backing supports GARDP\u00e2 $ s attempts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Base. Novo Nordisk Structure partners along with CARB-X to fight drug-resistant infections. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). International Commission: European Wellness and Digital Executive Agency. Research on taking AMR clinical countermeasures to the market. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the proper size of global pull incentives for anti-bacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entrance benefit for the development of brand new antibiotics. Harvard Kennedy College https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Market motivations and also antibiotic protection: an overview to the antibiotic sensitivity incentive. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An ambitious USG accelerated commitment for subscription-based investing in of unique antimicrobials as well as its expected roi. Center for Global Progression https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 investments in new antibiotics would certainly pay off \u00e2 $\" for every person. Workplace of Wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS steps up battle versus deadly contaminations complying with effective world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Compensation. Reform of the EU pharmaceutical legalisation. International Percentage https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Reimbursement styles to tackle market failings for antimicrobials: strategies taken in France, Germany, Sweden, the United Kingdom, and the USA. Wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers as well as Organizations. Coming from resistance to durability: what could the future antibiotic pipeline look like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp World Wellness Company. Incentivising the progression of new antibacterial therapies: 2023 report card by the Global AMR R&ampD Hub and also WHO. Global AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Performer, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK subscription model for antibiotics thought about successful? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimulations for the progression and also keeping on the marketplace of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, local, and nationwide sources of youngster death in 2000\u00e2 $ \"thirteen, with projections to educate post-2015 top priorities: an improved organized review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nQuadri, F. et al. Antibacterial drug shortages coming from 2001 to 2013: effects for medical practice. Clin. Infect. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French reporting system for drug lacks: summary as well as fads from 2012 to 2018: an empirical retrospective research. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et cetera. Assessment of that antibiotic consumption and also get access to aim ats in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical purchases information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Fighting the phonies: addressing substandard and falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving simpler to secure anti-biotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nAfrican Culture for Lab Medication. Policy concise and infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et cetera. National antibiotic consumption for individual make use of in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: review of main storage facilities supplies to in-patient care health and wellness amenities from 2017 to 2019 in Uganda. Trop. Med. Infect. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et cetera. Variants in the intake of antimicrobial medicines in the European area, 2014\u00e2 $ \"2018: findings and ramifications from ESAC-Net and also WHO Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Drug scarcity: sources, effect, and minimization strategies. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Patient gain access to in 14 high-income countries to new antibacterials accepted due to the United States Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals and Medical Tools Firm, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost prescription antibiotics: a follow-up inventory research in Europe, the United States, Canada as well as Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health technology for global health and wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Market Collaboration. The 2023 AMR Business Collaboration progression study: production as well as the atmosphere. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can clinical products be actually built on a charitable manner? Checking out item progression collaborations for neglected health conditions. Sci. Public law 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et cetera. Restart biomedical R&ampD in the global social rate of interest. Attributes 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Condition Management as well as Prevention. Africa CDC heads daring move to secure Africa\u00e2 $ s wellness future through developing a 50 billion dollar clinical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Arranging public-health patent licensing deals to enhance accessibility to wellness technologies: an insider\u00e2 $ s account. BMJ Glob. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company models for experimentation with cost criteria are required to attain decent pricing of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator. Conservation and gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Global Prescription Antibiotic Trial And Error Alliance. Shinogi, GARDP as well as CHAI declare site certificate as well as partnership agreements to handle microbial infections next to expanding accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Business Alliance. Leaving the laboratory: tracking the decrease in AMR R&ampD experts. amr Sector Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (twenty May 2022). G20. G20 contact us to action on antimicrobial resistance. G7G20 Files Data bank https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 October 2022). International Coalition on Getting Older &amp Transmittable Health Conditions Community of United States. 2024 AMR preparedness mark progress report. Assessing authorities action on AMR policy. Global Coalition on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and also Horticulture Institution of the United Nations, United Nations Setting Program, World Health And Wellness Association &amp. Planet Organization for Creature Wellness. International data source for tracking antimicrobial protection (AMR): nation self-assessment study (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Truck Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in th...

Integrating liver endpoints in medical tests of cardiovascular and also renal condition

.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Persp...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial intelligence directed screening process for cardiomyopathies in an obstetric populace: a pragmatic randomized medical trial

.Test style as well as oversightThe Assessment for PEripartum Cardiomyopathies with Artificial Intel...

Sustained HIV remission after allogeneic hematopoietic stem tissue hair transplant along with wild-type CCR5 contributor cells

.Attribute Medication, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remiss...

Senolytics target cell senescence-- however can they slow down aging?

.In the 1960s, United States anatomist Leonard Hayflick noted that replicative cells have a limited ...